Overcontrolled, undercontrolled, and resilient personality styles among patients with eating disorders.
Martina Isaksson, Ata Ghaderi, Martina Wolf-Arehult...
https://pubmed.ncbi.nlm.nih.gov/33863394Actively Recruiting
Led by Uppsala University Hospital · Updated on 2024-12-31
800
Participants Needed
1
Research Sites
987 weeks
Total Duration
U
Uppsala University Hospital
Lead Sponsor
F
Forte
Collaborating Sponsor
Researchers are studying Severe and Enduring Eating Disorders (SEED), which are long-lasting eating disorders affecting adolescents and adults. The study aims to understand the clinical, psychological, and biological factors that contribute to the development and persistence of SEED. It follows two groups of patients, one aged 14-17 and one aged 18 and older, to observe changes and impacts over time. Participants will be followed at multiple points: at the start (baseline), after treatment, two years later, and then at five, 10, and 20 years after baseline. During these times, they will undergo physical exams, provide blood samples, participate in interviews, and complete questionnaires. Caregivers of minors will also complete questionnaires. The study collects extensive data on psychiatric symptoms, personality, emotion regulation, loneliness, and inflammatory markers. Throughout the study, participants will be assessed with various interviews and questionnaires to measure eating disorder symptoms, psychosocial functioning, quality of life, and biological markers. Weekly weight checks occur during treatment and follow-up. Researchers will analyze how different factors influence the course of the disorder and treatment outcomes. The study may last up to 20 years for some participants and includes regular digital questionnaire responses and registry data reviews.
CONDITIONS
A Longitudinal Study of Severe and Enduring Eating Disorders
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At enrollment
Participants undergo initial assessments including clinical history, diagnostic interviews, physical examinations, and questionnaires to collect data on eating disorder symptoms, personality traits, emotion regulation, loneliness, and biomarkers.
1 visit (in-person)
Duration - Variable duration depending on individual treatment course
Participants receive treatment for their eating disorder while clinical, psychological, and physical data are collected, including weekly weight measurements and monitoring of treatment completion or dropout.
Weekly visits during treatment
Duration - Immediately after treatment or dropout
After treatment completion or dropout, participants complete questionnaires and assessments similar to baseline to evaluate changes in symptoms and other factors.
1 visit (in-person) or digital questionnaire
Duration - At 2 years post-baseline
Participants complete follow-up assessments including clinical interviews, physical examinations, questionnaires, and biomarker collection to monitor changes over time.
1 visit (in-person) and digital questionnaires
Duration - At 5, 10, and 20 years post-baseline
Participants are followed up at 5, 10, and 20 years post-baseline through national health registers and digital questionnaires to assess long-term outcomes related to eating disorders and associated factors.
Digital questionnaires and registry data retrieval
Total: 1 location
1
Uppsala University Hospital
Uppsala, Sweden, 75185
Actively Recruiting
M
Martina Isaksson, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Martina Isaksson, Ata Ghaderi, Martina Wolf-Arehult...
https://pubmed.ncbi.nlm.nih.gov/33863394Dennis Gibson, Philip S Mehler
https://pubmed.ncbi.nlm.nih.gov/31717370Marco Solmi, Nicola Veronese, Angela Favaro...
https://pubmed.ncbi.nlm.nih.gov/25462897Ziggi Ivan Santini, Veronica S C Pisinger, Line Nielsen...
https://pubmed.ncbi.nlm.nih.gov/33927599Roelie Hempel, Emily Vanderbleek, Thomas R Lynch
https://pubmed.ncbi.nlm.nih.gov/29384459Anna Oldershaw, Tony Lavender, Hannah Sallis...
https://pubmed.ncbi.nlm.nih.gov/26043394Alice-Beatrice Prefit, Diana Mirela Cândea, Aurora Szentagotai-Tătar
https://pubmed.ncbi.nlm.nih.gov/31479694Monica Martinussen, Oddgeir Friborg, Phöbe Schmierer...
https://pubmed.ncbi.nlm.nih.gov/27995489Elisabet Wentz, I Carina Gillberg, Henrik Anckarsäter...
https://pubmed.ncbi.nlm.nih.gov/19182181Kristen M Culbert, Sarah E Racine, Kelly L Klump
https://pubmed.ncbi.nlm.nih.gov/26095891